The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s tuberculosis diagnostics market report forecasts the tuberculosis diagnostics market size to grow to $2.76 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Tuberculosis Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Tuberculosis Diagnostics Market Size Forecast
The global tuberculosis diagnostics market is expected to grow from $1.99 billion in 2022 to $2.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The tuberculosis diagnostics market size is expected to reach $2.76 billion in 2027 at a CAGR of 6.6%.

Asia-Pacific held the largest tuberculosis diagnostics market share.

Key Tuberculosis Diagnostics Market Driver ­– Rise In The Incidence Of Tuberculosis
For instance, in March 2022, in the weekly report of the Centers for Disease Control and Prevention, a US-based national public health agency, tuberculosis infections in the United States increased by 9.4% in 2021, with a total of 7,860 TB cases were reported in 2021, an increase from 7,173 cases in 2020 but a decrease from 8,900 cases in 2019. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.

Request for A Sample Of The Global Tuberculosis Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Key Tuberculosis Diagnostics Market Trend – Technological Innovations
Major companies operating in the market are introducing new technologies, such as advanced point-of-care (POC) diagnostic methods that work on AI technology to sustain their position in the market. For instance, in August 2022, Fujifilm, a Japan-based company engaged in the manufacturing of medical imaging devices, partnered with Qure.ai, a US-based company engaged in the development of AI-enabled medical imaging solutions, and launched an advanced point-of-care (POC) diagnostic method. A battery-powered X-ray machine is used in this method for tuberculosis diagnosis. With the help of artificial intelligence, algorithms help in effective testing programs, offering ultra-portability, high accuracy, and efficient point-of-care diagnostic solutions.

Tuberculosis Diagnostics Market Segment
1) By Type: Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, Other Diagnostic Test Types
2) By Test: Nucleic Acid Testing (NAT), Skin Test / Mantoux Test (TST), Blood Test / Serology Test, SMEAR Microscopy, Cultured-Based Tests, Radiography Tests, Other Test
3) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
4) By End User: Hospitals and Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics and Research Facilities

Tuberculosis Diagnostics Market Major Players and Strategies
Major players in the tuberculosis diagnostics market are Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Cepheid, F Hoffmann-La Roche AG, Hologic Inc., AdvaCare Pharma, Thermo Fisher Scientific Inc., Siemens AG, Akonni Biosystems Inc., Alere Inc., Par Pharmaceutical, Lionex GmbH, Creative Diagnostics, bioMérieux Clinical Diagnostics, Epistem Limited, and Gen-Probe.

In March 2021, PerkinElmer, a US-based company engaged in diagnostics and scientific research, acquired Oxford Immunotec for $591 million. With this acquisition, PerkinElmer would expand its offering of infectious disease testing solutions, including tuberculosis detection, to serve clients worldwide. Oxford Immunotec is a UK-based company engaged in developing and commercializing proprietary assays for immunology and infectious disease.

The Tuberculosis Diagnostics Global Market Report 2023 covers regional data on tuberculosis diagnostics market size, tuberculosis diagnostics market trends and drivers, opportunities, strategies, and tuberculosis diagnostics market competitor analysis. The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

View More Reports Related To The Tuberculosis Diagnostics Market –
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2023
Molecular Diagnostics Devices And Equipment Global Market Report 2023
Transplant Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: